<SEC-DOCUMENT>0001193125-23-247386.txt : 20231117
<SEC-HEADER>0001193125-23-247386.hdr.sgml : 20231117
<ACCEPTANCE-DATETIME>20230929160856
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-23-247386
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20230929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Abivax S.A.
		CENTRAL INDEX KEY:			0001956827
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		7 BD HAUSSMANN
		CITY:			PARIS
		STATE:			I0
		ZIP:			75009
		BUSINESS PHONE:		01 53 83 09 63

	MAIL ADDRESS:	
		STREET 1:		7 BD HAUSSMANN
		CITY:			PARIS
		STATE:			I0
		ZIP:			75009
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g609070g0925071800127.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Divakar Gupta </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 212 479
6474 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">dgupta@cooley.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;29, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation
Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: &#8199;&#8194;Vanessa Robertson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">&#8195;Mary Mast </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">&#8195;Joshua
Gorsky </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">&#8195;Jason Drory </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Abivax SA </B></P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Amendment No.&nbsp;2 to Draft Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Submitted on September&nbsp;8, 2023 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>CIK No.&nbsp;0001956827 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and
Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Abivax SA (the &#147;<B><I>Company</I></B>&#148;), we are providing this letter in response to the comment of the staff (the
&#147;<B><I>Staff</I></B>&#148;) of the U.S. Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) Division of Corporation Finance contained in its letter, dated September&nbsp;20, 2023 (the &#147;<B><I>Comment
Letter</I></B>&#148;), relating to the Company&#146;s Amendment No.&nbsp;2 to the Confidential Draft Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1,</FONT> confidentially submitted on September&nbsp;8, 2023 (the
&#147;<B><I>Draft Registration Statement</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In response to the comment set forth in the Comment Letter, the Company has revised the
Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> (the &#147;<B><I>Registration Statement</I></B>&#148;) and is filing a Registration Statement with this response letter, which reflects changes made in response to the
comment contained in the Comment Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The numbering of the paragraph below corresponds to the numbering of the comment contained in the Comment
Letter, which, for your convenience, we have incorporated into this response letter in italics. Page references in the text of this response letter correspond to the page numbers of the Registration Statement.&nbsp;Capitalized terms used but not
otherwise defined in this letter shall have the meanings set forth in the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amendment No.</U><U></U><U>&nbsp;2 to Draft
Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> submitted September</U><U></U><U>&nbsp;8, 2023</U> </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 55 Hudson
Yards, New York, NY 10001-2157 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">t: (212) <FONT STYLE="white-space:nowrap">479-6000</FONT> f: (212)
<FONT STYLE="white-space:nowrap">479-6275</FONT> cooley.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g609070dsp001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 29, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Two
</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Risk Factors&#151;Risks Related to our Financial Position and Need for Additional Capital</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>We have significant debt commitments, which require us to meet certain operating covenants, and if we fail to comply with those covenants..., page 21</U>
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>1.</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>We note your disclosure stating that as security for the Kreos/Claret Financing, &#147;the Secured Lenders
benefit from the grant of first-ranking collateral on [y]our principal tangible and intangible assets, including . . . intellectual property rights in [y]our lead drug candidate[.]&#148; Please revise your disclosure to provide a separate risk
factor detailing the risks associated with pledging the intellectual property rights in your lead drug candidate as security for the Kreos/Claret Financing. </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In response to the Staff&#146;s comment, the Company has amended its disclosure on pages 8, 23 and 24. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * * </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 55 Hudson
Yards, New York, NY 10001-2157 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">t: (212) 479-6000 f: (212) 479-6275 cooley.com </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g609070dsp001.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Divakar Gupta </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 212 479 6474 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">dgupta@cooley.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please direct any questions or further comments concerning the Registration Statement or this response letter to either the undersigned at <FONT
STYLE="white-space:nowrap">(212)&nbsp;479-6474,</FONT> Marc Recht of Cooley LLP at (617) <FONT STYLE="white-space:nowrap">937-2316,</FONT> Ryan Sansom of Cooley LLP at (617) <FONT STYLE="white-space:nowrap">937-2335</FONT> or Denny Won of Cooley LLP
at <FONT STYLE="white-space:nowrap">(415)&nbsp;693-2032.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Divakar Gupta </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Divakar Gupta </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Marc de Garidel, Abivax SA </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Didier Blondel, Abivax SA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Marc
Recht, Cooley LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ryan Sansom, Cooley LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Denny Won, Cooley LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Nathan
Ajiashvili, Latham&nbsp;&amp; Watkins LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Alison A. Haggerty, Latham&nbsp;&amp; Watkins LLP </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 55 Hudson
Yards, New York, NY 10001-2157 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">t: (212) 479-6000 f: (212) 479-6275 cooley.com </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g609070dsp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g609070dsp001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  L (@# 2(  A$! Q$!_\0
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M&_L@?\%'_''_  2\BNOA+\6? ^L7&EZ9,\]C%O$5YIXD?<PB+?NYH&;>ZE6
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A>&PB?UC'U+5):65*FW:"=[W<M7HE9M'34445ZY^/G__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g609070g0925071800127.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g609070g0925071800127.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  L (@# 2(  A$! Q$!_\0
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M1SCW./I4>G?%.2.]%OKNF&V4GF2,,"GU4\D?0_A2]M"]KFBR;&N'/R?*ZO\
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MK<B^*>@_:M-BUF!?WUK\DN.IC)X/X'^9H7QT#\-FOS+_ ,3)1]DZ\^;CA_\
MOGYOKQ7?7$$5U;2V\R!XI4*.I[@C!%> ?\([,_C!O#T$N_\ TDQ[P<@*.K'W
M"YS^-.K>$KQZF66>RQE#V5?_ )=/F_[=ZH]!^%>A_9=+FUB9?WMV=D1/41@\
M_F?Y"BN]M;:*SM(;:!0D4*!$4=@!@45O"/+&QXF-Q,L37E5?7\NA+56[TRPO
M\?;+&VN,=/.B5\?F*M451S1DXN\78J6FEZ?8$FSL+6V)ZF&%4S^0JW110$I.
M3O)W*]W86=^@2\M(+A1T6:,.!^=-M--L-/W?8K*VMMW7R8E3/Y"K5%*RW'SR
MY>6^@4R6&*>)HYHTDC;JKJ"#^!I]%,E.VJ*%OHFDVDHEMM+LH)!T>*W12/Q
MJ_110DD5*<IN\G<A:TMFG\YK>(R@YWE!N_.IJ**!-M[E"?0](NIC-<:7932G
MJ\ENC,?Q(JY'%'#&L<4:QQJ,*JC 'X4^BE9#<Y25FS*\2:RF@Z#=:@V"\:XC
M4_Q.>%'Y_IFN)^%FCNXN_$%UEI)F,43-U/.7;\3Q^!KL/$?ABT\3P007ES=1
MQ0L7"0,H#'IDY4].?S-:6G6$&EZ=;V-L"(8$"+GJ<=S[GK6;7-4N^AZ<:L:&
1 <8_%4>K\ET+-%%%:GE'_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
